Risk factor
Low price volatility
Profitability factor
Undervalued vs peers
About
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of...
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, of fair value on EV/E
Target Price
The average target price of HLN.L is 408 and suggests 11% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell